Beyond Prescriptions: What a Sustainable GLP-1 Strategy Looks Like for Employers

7/27/26

GLP-1 medications are changing the conversation around weight management and employee health.

For employers, the question is no longer whether these medications matter – it’s how to respond thoughtfully as demand, expectations, and costs continue to evolve.

A more complex employer challenge is emerging

Supporting GLP-1 use isn’t just a clinical or coverage decision. It sits at the intersection of several competing priorities:

  • Expanding the access to care employees’ value
  • Managing rapidly rising pharmacy costs
  • Improving long-term health outcomes
  • Creating a benefits experience that feels fair and sustainable

Each of these factors matters and they don’t always move in the same direction.

Why this isn’t just about cost – or coverage

Some organizations start by focusing on cost control. Others focus on access. But most quickly realize that neither approach, on its own, fully solves the challenge.

Expanding access without guardrails can create financial unpredictability. Restricting access too heavily can impact employee experience and engagement.

That tension is what many employers are navigating today: How do you support employees while balancing access, affordability, and long-term sustainability?

The long-term picture matters

GLP-1 medications for weight management can play an important role in improving health outcomes. At the same time, they are often part of a broader, ongoing journey.

Employers are beginning to ask practical questions like:

  • What does success look like beyond initial results?
  • How should support evolve over time?
  • How do we think about continuity of care and engagement?

There isn’t one right answer – but these questions point to a broader shift: from treating GLP-1s as a short-term solution to planning for a longer-term strategy.

What leading organizations are considering

As employers refine their approach, several themes are emerging:

  • Structure: Creating clearer parameters around eligibility, funding, and use
  • Flexibility: Allowing room to adapt as demand and clinical guidance evolve
  • Whole-person support: Recognizing that medication is often part of a broader health journey
  • Sustainability: Balancing immediate needs with long-term affordability

These considerations don’t lead to a single model – but they do suggest that a more integrated approach may be needed.

Where existing benefit tools can play a role

Rather than starting from scratch, some employers are looking at how existing tools can be used more intentionally.

For example:

  • Health Reimbursement Accounts (HRAs) can introduce more structure and predictability on how costs are managed
  • Lifestyle Spending Accounts (LSAs) can support broader wellbeing and day-to-day health behaviors

Individually, these tools are familiar. Together, they can be adapted to support both access and longer-term engagement – depending on how they’re designed.

Bringing it together

There’s no single blueprint for a GLP-1 strategy – and that’s part of the challenge.

But what’s becoming clearer is that sustainable approaches tend to:

  • Acknowledge both cost and care considerations
  • Create structure without eliminating flexibility
  • Support employees beyond a single point of intervention

Solutions like pairing an HRA with an LSA is one way to move in that direction, but it is most effective when they are part of a broader, thoughtfully designed strategy.

A conversation worth having

As GLP-1 use continues to grow, employers have an opportunity to step back and define what success looks like for their organization – both today and in the future. We work with employers to explore these questions and design approaches that reflect their goals, workforce, and priorities.

Because in a changing landscape, the goal isn’t just to respond, it’s to build something that lasts.